tiprankstipranks
Advertisement
Advertisement
ARS Pharmaceuticals Lawsuit Focuses on Alleged Neffy Coverage Disclosures and SPRY Stock Drop 
PremiumClass ActionARS Pharmaceuticals Lawsuit Focuses on Alleged Neffy Coverage Disclosures and SPRY Stock Drop 
6d ago
SPRY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SPRY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
10d ago
ARS Pharmaceuticals Lawsuit Alleges Investors Were Misled Before SPRY Stock Drop
Premium
Class Action
ARS Pharmaceuticals Lawsuit Alleges Investors Were Misled Before SPRY Stock Drop
13d ago
Closing Bell Movers: Micron soars 14% after beat and raise
PremiumThe FlyClosing Bell Movers: Micron soars 14% after beat and raise
2M ago
ARS reports no new commercial formulary additions, coverage decisions for neffy
Premium
The Fly
ARS reports no new commercial formulary additions, coverage decisions for neffy
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Midday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
PremiumThe FlyMidday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
3M ago
Morning Movers: Cerebras Systems pulls back after smash IPO
Premium
The Fly
Morning Movers: Cerebras Systems pulls back after smash IPO
3M ago
Options Volatility and Implied Earnings Moves Today, May 15, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 15, 2026
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100